A clinical-stage pharmaceutical company in Israel is preparing to launch a study on a proprietary cannabinoid-based epilepsy treatment. Tel Aviv-based …
More than half of cannabis-consuming Parkinson’s disease (PD) patients report experiencing clinical benefits, according to a survey. According to the …